962
Participants
Start Date
December 31, 2009
Primary Completion Date
October 31, 2010
Study Completion Date
October 31, 2010
Blood draw
Group 1.1- 0.5 mL dose of 13vPnC was administered in the deltoid muscle at year 0 and 0.5 mL dose of 13vPnC was administered in the deltoid muscle at year 1 Group 1.2- 0.5 mL dose of 13vPnC was administered in the deltoid muscle at year 0 and 0.5 mL dose of 23vPS was administered in the deltoid muscle at year 1 Group 2- 0.5 mL dose of 23vPS was administered in the deltoid muscle at year 0 and 0.5 mL dose of 13vPnC was administered in the deltoid muscle at year 1
Blood draw
Group 1- 0.5 mL dose of 13vPnC was administered in the deltoid muscle at year 0 and year 1 Group 2- 0.5 mL dose of 23vPS was administered in the deltoid muscle at year 0 and 0.5 mL dose of 13vPNC was administered in the deltoid muscle at year 1
Pfizer Investigational Site, Jefferson
Pfizer Investigational Site, Carnegie
Pfizer Investigational Site, Pittsburgh
Pfizer Investigational Site, Grove City
Pfizer Investigational Site, Cary
Pfizer Investigational Site, Raleigh
Pfizer Investigational Site, Raleigh
Pfizer Investigational Site, Durham
Pfizer Investigational Site, Mt. Pleasant
Pfizer Investigational Site, Greer
Pfizer Investigational Site, Pinellas Park
Pfizer Investigational Site, Bristol
Pfizer Investigational Site, Lexington
Pfizer Investigational Site, Cleveland
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, Penndel
Pfizer Investigational Site, Kansas City
Pfizer Investigational Site, Wichita
Pfizer Investigational Site, Austin
Pfizer Investigational Site, Denver
Pfizer Investigational Site, Meridian
Pfizer Investigational Site, Chandler
Pfizer Investigational Site, Phoenix
Pfizer Investigational Site, Corvallis
Pfizer Investigational Site, Eugene
Pfizer Investigational Site, Seattle
Pfizer Investigational Site, Rochester
Pfizer Investigational Site, Nashville
Lead Sponsor
Pfizer
INDUSTRY